Hengrui and Kailera report positive phase 3 results for dual GLP-1/GIP agonist in obesity treatment Read more
Emcure Pharmaceuticals and Sanofi India sign exclusive distribution agreement for oral anti-diabetic products in India Read more
Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart Read more